IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome

Guillain-Barré syndrome (GBS) is an acute autoimmune-mediated inflammatory demyelinating disease that causes rapidly progressing paralysis and occasionally respiratory failure. We hypothesized that interleukin (IL)-17 and IL-22 are elevated in GBS and participate in the autoimmune inflammatory respo...

Full description

Saved in:
Bibliographic Details
Main Authors: Shujuan Li, Ming Yu, Haifeng Li, Hongliang Zhang, Yanfang Jiang
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/260473
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557022257610752
author Shujuan Li
Ming Yu
Haifeng Li
Hongliang Zhang
Yanfang Jiang
author_facet Shujuan Li
Ming Yu
Haifeng Li
Hongliang Zhang
Yanfang Jiang
author_sort Shujuan Li
collection DOAJ
description Guillain-Barré syndrome (GBS) is an acute autoimmune-mediated inflammatory demyelinating disease that causes rapidly progressing paralysis and occasionally respiratory failure. We hypothesized that interleukin (IL)-17 and IL-22 are elevated in GBS and participate in the autoimmune inflammatory response of GBS. We used sandwich enzyme-linked immunosorbent assay (ELISA) to measure the IL-17 and IL-22 levels in the CSF, and plasma from 22 GBS patients at the acute phase and 18 healthy controls (HC). The results show that CSF and plasma levels of IL-17 and IL-22 are elevated in GBS patients compared with HC. IL-17 and IL-22 levels in CSF, respectively, are correlated with GBS disability scale scores (GDSs). Meanwhile, IL-17 and IL-22 levels in CSF, IL-22 in CSF, and plasma of GBS patients have positive correlation, respectively. The increased levels of IL-17 and IL-22 in CSF may be explained by the disruption of blood-brain barrier (BBB) and peripheral nervous system (PNS) local inflammation in GBS. Meanwhile, the elevated levels of these two cytokines in plasma suggest the activation of Th17 and Th22 cells in the systemic immune response of GBS. Our data provide preliminary evidence that GBS is associated with high levels of IL-17 and IL-22 in CSF and plasma. These cytokines display pathogenic potential and may serve as useful biomarkers for GBS.
format Article
id doaj-art-63e25b121d9e489a98292f65d051b61d
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-63e25b121d9e489a98292f65d051b61d2025-02-03T05:43:52ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/260473260473IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré SyndromeShujuan Li0Ming Yu1Haifeng Li2Hongliang Zhang3Yanfang Jiang4Department of Neurology, The First Hospital, Jilin University, Jilin Province, Changchun 130021, ChinaDepartment of Neurology, The Affiliated Hospital of Jiangsu University, Jiangsu Province, Zhenjiang 212001, ChinaDepartment of Neurology, The Affiliated Hospital of Medical College, Qingdao University, Shandong Province, Qingdao 266003, ChinaDepartment of Neurology, The First Hospital, Jilin University, Jilin Province, Changchun 130021, ChinaDepartment of Central Laboratory, The Second Part of the First Hospital, Jilin University, Jilin Province, Changchun 130032, ChinaGuillain-Barré syndrome (GBS) is an acute autoimmune-mediated inflammatory demyelinating disease that causes rapidly progressing paralysis and occasionally respiratory failure. We hypothesized that interleukin (IL)-17 and IL-22 are elevated in GBS and participate in the autoimmune inflammatory response of GBS. We used sandwich enzyme-linked immunosorbent assay (ELISA) to measure the IL-17 and IL-22 levels in the CSF, and plasma from 22 GBS patients at the acute phase and 18 healthy controls (HC). The results show that CSF and plasma levels of IL-17 and IL-22 are elevated in GBS patients compared with HC. IL-17 and IL-22 levels in CSF, respectively, are correlated with GBS disability scale scores (GDSs). Meanwhile, IL-17 and IL-22 levels in CSF, IL-22 in CSF, and plasma of GBS patients have positive correlation, respectively. The increased levels of IL-17 and IL-22 in CSF may be explained by the disruption of blood-brain barrier (BBB) and peripheral nervous system (PNS) local inflammation in GBS. Meanwhile, the elevated levels of these two cytokines in plasma suggest the activation of Th17 and Th22 cells in the systemic immune response of GBS. Our data provide preliminary evidence that GBS is associated with high levels of IL-17 and IL-22 in CSF and plasma. These cytokines display pathogenic potential and may serve as useful biomarkers for GBS.http://dx.doi.org/10.1155/2012/260473
spellingShingle Shujuan Li
Ming Yu
Haifeng Li
Hongliang Zhang
Yanfang Jiang
IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome
Mediators of Inflammation
title IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome
title_full IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome
title_fullStr IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome
title_full_unstemmed IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome
title_short IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré Syndrome
title_sort il 17 and il 22 in cerebrospinal fluid and plasma are elevated in guillain barre syndrome
url http://dx.doi.org/10.1155/2012/260473
work_keys_str_mv AT shujuanli il17andil22incerebrospinalfluidandplasmaareelevatedinguillainbarresyndrome
AT mingyu il17andil22incerebrospinalfluidandplasmaareelevatedinguillainbarresyndrome
AT haifengli il17andil22incerebrospinalfluidandplasmaareelevatedinguillainbarresyndrome
AT hongliangzhang il17andil22incerebrospinalfluidandplasmaareelevatedinguillainbarresyndrome
AT yanfangjiang il17andil22incerebrospinalfluidandplasmaareelevatedinguillainbarresyndrome